Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Genentech, Inc.